Weight-loss drugs are a godsend, so of course insurers drop coverage

Now Massachusetts insurers — yes, companies like Blue Cross Blue Shield of Massachusetts and Harvard Pilgrim Health Care — ...
India West

Tips To Manage Sugar Spikes And Weight Gain

With the Indian festival season here and other holidays looming culinary delights await and it is quite easy to get carried away. However, it is equally important to maintain a healthy balance to ...
Zacks.com on MSN

NVO Down 10% in 3 Months: Is This an Indication to Sell the Stock?

Novo Nordisk stock falls 10% in three months as guidance cuts, GLP-1 rivalry and looming U.S. price resets cloud growth and ...

Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Presented robust CRB-701 clinical data at ESMO 2025 - 3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in ...

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

On September 25, 2025, Anebulo announced the first subjects dosed in a Phase 1 single ascending dose ("SAD") study of an intravenous (IV) formulation of its lead drug candidate selonabant. Selonabant ...
Everyday Health on MSN

I Tried GLP-1s for Weight Loss: 6 Things I Wish I Knew Before Starting

Real users give insights on taking GLP-1 medications for weight loss, including experiences with benefits, stigma, side ...